Kamal Fariborz 4
4 · 4D Molecular Therapeutics, Inc. · Filed Feb 14, 2023
Insider Transaction Report
Form 4
Kamal Fariborz
President & COO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-10+75,000→ 75,000 totalExercise: $20.24Exp: 2033-02-09→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 10, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company